CYTOKINETICS, INCORPORATED Increase (Decrease) in Prepaid Expense and Other Assets
CYTOKINETICS, INCORPORATED (CYTK) reported Increase (Decrease) in Prepaid Expense and Other Assets of $2.79 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-06
- CYTOKINETICS, INCORPORATED increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $4.84M, a 4.44% increase year-over-year.
- CYTOKINETICS, INCORPORATED increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$2.06M, a 647.07% decline year-over-year.
- CYTOKINETICS, INCORPORATED increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $4.20M, a 50.30% decline year-over-year.
- CYTOKINETICS, INCORPORATED increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$6.28M.
- CYTOKINETICS, INCORPORATED increase (decrease) in prepaid expense and other assets for fiscal 2025 was $2.93M, a 20.30% increase from fiscal 2024.
- CYTOKINETICS, INCORPORATED increase (decrease) in prepaid expense and other assets for fiscal 2024 was $2.44M.
- CYTOKINETICS, INCORPORATED increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$1.60M, a 121.53% decline from fiscal 2022.
- CYTOKINETICS, INCORPORATED increase (decrease) in prepaid expense and other assets for fiscal 2022 was $7.41M, a 0.45% increase from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 167 month | Increase (Decrease) in Prepaid Expense and Other Assets 170 month | Increase (Decrease) in Prepaid Expense and Other Assets 173 month | Increase (Decrease) in Prepaid Expense and Other Assets 176 month | Increase (Decrease) in Prepaid Expense and Other Assets 179 month | Increase (Decrease) in Prepaid Expense and Other Assets 182 month | Increase (Decrease) in Prepaid Expense and Other Assets 185 month | Increase (Decrease) in Prepaid Expense and Other Assets 188 month | Increase (Decrease) in Prepaid Expense and Other Assets 191 month | Increase (Decrease) in Prepaid Expense and Other Assets 194 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.79M 10-Q · filed 2026-08-06 | $6.98M derived: sum of 3 quarters · filed 2026-08-06 | $706.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||
| 2026-03-31 | -$2.06M 10-Q · filed 2026-05-05 | $2.14M derived: sum of 2 quarters · filed 2026-05-05 | -$4.14M derived: sum of 3 quarters · filed 2026-05-05 | $500.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||
| 2025-12-31 | $4.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$2.08M derived: sum of 2 quarters · filed 2026-02-26 | $2.56M derived: sum of 3 quarters · filed 2026-08-06 | $2.93M 10-K · filed 2026-02-26 | ||||||||||
| 2025-09-30 | -$6.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.64M derived: sum of 2 quarters · filed 2026-08-06 | -$1.26M 10-Q · filed 2025-11-05 | $7.18M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||
| 2025-06-30 | $4.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $5.01M 10-Q · filed 2026-08-06 | $13.46M derived: sum of 3 quarters · filed 2026-08-06 | $8.98M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||
| 2025-03-31 | $376.00K 10-Q · filed 2026-05-05 | $8.82M derived: sum of 2 quarters · filed 2026-05-05 | $4.34M derived: sum of 3 quarters · filed 2026-05-05 | -$3.82M derived: sum of 4 quarters · filed 2026-05-05 | ||||||||||
| 2024-12-31 | $8.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.97M derived: sum of 2 quarters · filed 2026-02-26 | -$4.19M derived: sum of 3 quarters · filed 2026-02-26 | $2.44M 10-K · filed 2026-02-26 | ||||||||||
| 2024-09-30 | -$4.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$12.64M derived: sum of 2 quarters · filed 2025-11-05 | -$6.01M 10-Q · filed 2025-11-05 | -$14.54M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||
| 2024-06-30 | -$8.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$1.53M 10-Q · filed 2025-08-07 | -$10.06M derived: sum of 3 quarters · filed 2026-02-26 | -$10.41M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||
| 2024-03-31 | $6.63M 10-Q · filed 2025-05-06 | -$1.90M derived: sum of 2 quarters · filed 2026-02-26 | -$2.25M derived: sum of 3 quarters · filed 2026-02-26 | $3.41M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||
| 2023-12-31 | -$8.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$8.88M derived: sum of 2 quarters · filed 2026-02-26 | -$3.22M derived: sum of 3 quarters · filed 2026-02-26 | -$1.60M 10-K · filed 2026-02-26 | ||||||||||
| 2023-09-30 | -$342.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $5.31M derived: sum of 2 quarters · filed 2024-11-07 | $6.94M 10-Q · filed 2024-11-07 | $5.41M derived: sum of 4 quarters · filed 2025-02-27 | ||||||||||
| 2023-06-30 | $5.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $7.28M 10-Q · filed 2024-08-09 | $5.75M derived: sum of 3 quarters · filed 2025-02-27 | $6.66M derived: sum of 4 quarters · filed 2025-02-27 | ||||||||||
| 2023-03-31 | $1.63M 10-Q · filed 2024-05-10 | $99.00K derived: sum of 2 quarters · filed 2025-02-27 | $1.01M derived: sum of 3 quarters · filed 2025-02-27 | $7.62M derived: sum of 4 quarters · filed 2025-02-27 | ||||||||||
| 2022-12-31 | -$1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$619.00K derived: sum of 2 quarters · filed 2025-02-27 | $5.99M derived: sum of 3 quarters · filed 2025-02-27 | $7.41M 10-K · filed 2025-02-27 | ||||||||||
| 2022-09-30 | $909.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $7.52M derived: sum of 2 quarters · filed 2023-11-03 | $8.94M 10-Q · filed 2023-11-03 | $5.08M derived: sum of 4 quarters · filed 2024-02-28 | ||||||||||
| 2022-06-30 | $6.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $8.03M 10-Q · filed 2023-08-03 | $4.17M derived: sum of 3 quarters · filed 2024-02-28 | $9.83M derived: sum of 4 quarters · filed 2024-02-28 | ||||||||||
| 2022-03-31 | $1.42M 10-Q · filed 2023-05-05 | -$2.44M derived: sum of 2 quarters · filed 2024-02-28 | $3.22M derived: sum of 3 quarters · filed 2024-02-28 | $11.48M derived: sum of 4 quarters · filed 2024-02-28 | ||||||||||
| 2021-12-31 | -$3.86M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.80M derived: sum of 2 quarters · filed 2024-02-28 | $10.06M derived: sum of 3 quarters · filed 2024-02-28 | $7.38M 10-K · filed 2024-02-28 | ||||||||||
| 2021-09-30 | $5.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $13.92M derived: sum of 2 quarters · filed 2022-11-04 | $11.24M 10-Q · filed 2022-11-04 | $16.70M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||||
| 2021-06-30 | $8.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $5.58M 10-Q · filed 2022-08-05 | $11.04M derived: sum of 3 quarters · filed 2023-03-01 | $10.58M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||||
| 2021-03-31 | -$2.68M 10-Q · filed 2022-05-06 | $2.78M derived: sum of 2 quarters · filed 2023-03-01 | $2.33M derived: sum of 3 quarters · filed 2023-03-01 | $3.43M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||||
| 2020-12-31 | $5.46M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $5.00M derived: sum of 2 quarters · filed 2023-03-01 | $6.11M derived: sum of 3 quarters · filed 2023-03-01 | $5.16M 10-K · filed 2023-03-01 | ||||||||||
| 2020-09-30 | -$454.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $655.00K derived: sum of 2 quarters · filed 2021-11-05 | -$294.00K 10-Q · filed 2021-11-05 | $1.82M derived: sum of 4 quarters · filed 2022-02-25 | ||||||||||
| 2020-06-30 | $1.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $160.00K 10-Q · filed 2021-08-06 | $2.28M derived: sum of 3 quarters · filed 2022-02-25 | $3.76M derived: sum of 4 quarters · filed 2022-02-25 | ||||||||||
| 2020-03-31 | -$949.00K 10-Q · filed 2021-05-07 | $1.17M derived: sum of 2 quarters · filed 2022-02-25 | $2.65M derived: sum of 3 quarters · filed 2022-02-25 | $1.93M derived: sum of 4 quarters · filed 2022-02-25 | ||||||||||
| 2019-12-31 | $2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $3.60M derived: sum of 2 quarters · filed 2022-02-25 | $2.88M derived: sum of 3 quarters · filed 2022-02-25 | $3.86M 10-K · filed 2022-02-25 | ||||||||||
| 2019-09-30 | $1.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | $762.00K derived: sum of 2 quarters · filed 2020-08-07 | $1.75M 10-Q · filed 2019-11-01 | $1.95M derived: sum of 4 quarters · filed 2020-08-07 | ||||||||||
| 2019-06-30 | -$717.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $266.00K 10-Q · filed 2020-08-07 | $475.00K derived: sum of 3 quarters · filed 2020-08-07 | $637.00K derived: sum of 4 quarters · filed 2020-08-07 | ||||||||||
| 2019-03-31 | $983.00K 10-Q · filed 2020-05-08 | $1.19M derived: sum of 2 quarters · filed 2020-05-08 | $1.35M derived: sum of 3 quarters · filed 2020-05-08 | $572.00K derived: sum of 4 quarters · filed 2020-05-08 | ||||||||||
| 2018-12-31 | $209.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | $371.00K derived: sum of 2 quarters · filed 2020-03-04 | -$411.00K derived: sum of 3 quarters · filed 2020-03-04 | -$1.82M 10-K · filed 2020-03-04 | ||||||||||
| 2018-09-30 | $162.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | -$620.00K derived: sum of 2 quarters · filed 2019-11-01 | -$2.03M 10-Q · filed 2019-11-01 | -$2.17M derived: sum of 4 quarters · filed 2019-11-01 | ||||||||||
| 2018-06-30 | -$782.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$2.19M 10-Q · filed 2019-08-09 | -$2.33M derived: sum of 3 quarters · filed 2019-08-09 | -$2.69M derived: sum of 4 quarters · filed 2019-08-09 | ||||||||||
| 2018-03-31 | -$1.41M 10-Q · filed 2019-05-09 | -$1.55M derived: sum of 2 quarters · filed 2019-05-09 | -$1.91M derived: sum of 3 quarters · filed 2019-05-09 | -$484.00K derived: sum of 4 quarters · filed 2019-05-09 | ||||||||||
| 2017-12-31 | -$147.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$502.00K derived: sum of 2 quarters · filed 2019-03-07 | $922.00K derived: sum of 3 quarters · filed 2019-03-07 | $2.16M 10-K · filed 2019-03-07 | ||||||||||
| 2017-09-30 | -$355.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $1.07M derived: sum of 2 quarters · filed 2018-11-09 | $2.31M 10-Q · filed 2018-11-09 | $2.09M derived: sum of 4 quarters · filed 2018-11-09 | ||||||||||
| 2017-06-30 | $1.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $2.66M 10-Q · filed 2018-08-07 | $2.45M derived: sum of 3 quarters · filed 2018-08-07 | -$1.23M derived: sum of 4 quarters · filed 2018-08-07 | ||||||||||
| 2017-03-31 | $1.24M 10-Q · filed 2018-05-10 | $1.02M derived: sum of 2 quarters · filed 2018-05-10 | -$2.65M derived: sum of 3 quarters · filed 2018-05-10 | $904.00K derived: sum of 4 quarters · filed 2018-05-10 | ||||||||||
| 2016-12-31 | -$215.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | -$3.89M derived: sum of 2 quarters · filed 2018-03-05 | -$335.00K derived: sum of 3 quarters · filed 2018-03-05 | $707.00K 10-K · filed 2018-03-05 | ||||||||||
| 2016-09-30 | -$3.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | -$120.00K derived: sum of 2 quarters · filed 2017-11-03 | $922.00K 10-Q · filed 2017-11-03 | $92.00K derived: sum of 4 quarters · filed 2018-03-05 | ||||||||||
| 2016-06-30 | $3.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $4.60M 10-Q · filed 2017-08-04 | $3.77M derived: sum of 3 quarters · filed 2018-03-05 | $3.98M derived: sum of 4 quarters · filed 2018-03-05 | ||||||||||
| 2016-03-31 | $1.04M 10-Q · filed 2017-05-04 | $212.00K derived: sum of 2 quarters · filed 2018-03-05 | $423.00K derived: sum of 3 quarters · filed 2018-03-05 | $722.00K derived: sum of 4 quarters · filed 2018-03-05 | ||||||||||
| 2015-12-31 | -$830.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-05 | -$619.00K derived: sum of 2 quarters · filed 2018-03-05 | -$320.00K derived: sum of 3 quarters · filed 2018-03-05 | $396.00K 10-K · filed 2018-03-05 | ||||||||||
| 2015-09-30 | $211.00K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2016-12-15 | $510.00K derived: sum of 2 quarters · filed 2016-12-15 | $1.23M 10-Q/A · filed 2016-12-15 | $679.00K derived: sum of 4 quarters · filed 2017-03-06 | ||||||||||
| 2015-06-30 | $299.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $1.01M 10-Q · filed 2016-08-04 | $468.00K derived: sum of 3 quarters · filed 2017-03-06 | $263.00K derived: sum of 4 quarters · filed 2017-03-06 | ||||||||||
| 2015-03-31 | $716.00K 10-Q · filed 2016-05-05 | $169.00K derived: sum of 2 quarters · filed 2017-03-06 | -$36.00K derived: sum of 3 quarters · filed 2017-03-06 | $382.00K derived: sum of 4 quarters · filed 2017-03-06 | ||||||||||
| 2014-12-31 | -$547.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | -$752.00K derived: sum of 2 quarters · filed 2017-03-06 | -$334.00K derived: sum of 3 quarters · filed 2017-03-06 | -$274.00K 10-K · filed 2017-03-06 | ||||||||||
| 2014-09-30 | -$205.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $213.00K derived: sum of 2 quarters · filed 2015-11-05 | $273.00K 10-Q · filed 2015-11-05 | $199.00K derived: sum of 4 quarters · filed 2016-03-03 | ||||||||||
| 2014-06-30 | $418.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $478.00K 10-Q · filed 2015-08-05 | $404.00K derived: sum of 3 quarters · filed 2016-03-03 | $116.00K derived: sum of 4 quarters · filed 2016-03-03 | ||||||||||
| 2014-03-31 | $60.00K 10-Q · filed 2015-05-04 | -$14.00K derived: sum of 2 quarters · filed 2016-03-03 | -$302.00K derived: sum of 3 quarters · filed 2016-03-03 | -$74.00K derived: sum of 4 quarters · filed 2016-03-03 | ||||||||||
| 2013-12-31 | -$74.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | -$362.00K derived: sum of 2 quarters · filed 2016-03-03 | -$134.00K derived: sum of 3 quarters · filed 2016-03-03 | -$818.00K 10-K · filed 2016-03-03 | ||||||||||
| 2013-09-30 | -$288.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$60.00K derived: sum of 2 quarters · filed 2014-11-06 | -$744.00K 10-Q · filed 2014-11-06 | -$1.48M derived: sum of 4 quarters · filed 2015-03-06 | $1.83M 10-Q · filed 2013-11-06 | |||||||||
| 2013-06-30 | $228.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$456.00K 10-Q · filed 2014-08-07 | -$1.19M derived: sum of 3 quarters · filed 2015-03-06 | -$515.00K derived: sum of 4 quarters · filed 2015-03-06 | $2.12M 10-Q · filed 2013-08-07 | |||||||||
| 2013-03-31 | -$684.00K 10-Q · filed 2014-05-07 | -$1.42M derived: sum of 2 quarters · filed 2015-03-06 | -$743.00K derived: sum of 3 quarters · filed 2015-03-06 | -$319.00K derived: sum of 4 quarters · filed 2015-03-06 | $1.89M 10-Q · filed 2013-05-08 | |||||||||
| 2012-12-31 | -$736.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-06 | -$59.00K derived: sum of 2 quarters · filed 2015-03-06 | $365.00K derived: sum of 3 quarters · filed 2015-03-06 | $320.00K 10-K · filed 2015-03-06 | $2.58M 10-K · filed 2013-03-15 | |||||||||
| 2012-09-30 | $677.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $1.10M derived: sum of 2 quarters · filed 2013-11-06 | $1.06M 10-Q · filed 2013-11-06 | $1.01M derived: sum of 4 quarters · filed 2014-03-07 | $3.31M 10-Q · filed 2012-11-07 | |||||||||
| 2012-06-30 | $424.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $379.00K 10-Q · filed 2013-08-07 | $337.00K derived: sum of 3 quarters · filed 2014-03-07 | -$389.00K derived: sum of 4 quarters · filed 2014-03-07 | $2.64M 10-Q · filed 2012-08-06 | |||||||||
| 2012-03-31 | -$45.00K 10-Q · filed 2013-05-08 | -$87.00K derived: sum of 2 quarters · filed 2014-03-07 | -$813.00K derived: sum of 3 quarters · filed 2014-03-07 | -$1.06M derived: sum of 4 quarters · filed 2014-03-07 | $2.21M 10-Q · filed 2012-05-04 | |||||||||
| 2011-12-31 | -$42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | -$768.00K derived: sum of 2 quarters · filed 2014-03-07 | -$1.02M derived: sum of 3 quarters · filed 2014-03-07 | $238.00K 10-K · filed 2014-03-07 | $2.26M 10-K · filed 2012-03-13 | |||||||||
| 2011-09-30 | -$726.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | -$975.00K derived: sum of 2 quarters · filed 2012-11-07 | $280.00K 10-Q · filed 2012-11-07 | $197.00K derived: sum of 4 quarters · filed 2013-03-15 | $2.30M 10-Q · filed 2011-11-04 | |||||||||
| 2011-06-30 | -$249.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | $1.01M 10-Q · filed 2012-08-06 | $923.00K derived: sum of 3 quarters · filed 2013-03-15 | $358.00K derived: sum of 4 quarters · filed 2013-03-15 | $3.03M 10-Q · filed 2011-08-04 | |||||||||
| 2011-03-31 | $1.25M 10-Q · filed 2012-05-04 | $1.17M derived: sum of 2 quarters · filed 2013-03-15 | $607.00K derived: sum of 3 quarters · filed 2013-03-15 | |||||||||||
| 2010-12-31 | -$83.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$648.00K derived: sum of 2 quarters · filed 2013-03-15 | -$304.00K 10-K · filed 2013-03-15 | |||||||||||
| 2010-09-30 | -$565.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | -$221.00K 10-Q · filed 2011-11-04 | ||||||||||||
| 2010-06-30 | $344.00K 10-Q · filed 2011-08-04 | |||||||||||||
| 2009-12-31 | $166.00K 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |